Chromadex Historical Financial Ratios
| CDXC Stock | USD 7.72 0.08 1.05% |
Chromadex Corp is presently reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.58 or Days Sales Outstanding of 21.72 will help investors to properly organize and evaluate Chromadex Corp financial condition quickly.
Chromadex |
About Chromadex Financial Ratios Analysis
Chromadex CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Chromadex Corp investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Chromadex financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Chromadex Corp history.
Chromadex Corp Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Chromadex Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Chromadex Corp sales, a figure that is much harder to manipulate than other Chromadex Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Most ratios from Chromadex Corp's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Chromadex Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.At present, Chromadex Corp's Operating Cash Flow Per Share is projected to increase slightly based on the last few years of reporting. The current year's Average Payables is expected to grow to about 6.3 M, whereas Price To Sales Ratio is forecasted to decline to 1.22.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 28.28 | 42.97 | 22.86 | 21.72 | PTB Ratio | 7.92 | 4.09 | 3.77 | 3.58 |
Chromadex Corp fundamentals Correlations
Click cells to compare fundamentals
Chromadex Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chromadex Corp fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 5.31 | 4.95 | 3.73 | 1.63 | 1.28 | 1.22 | |
| Ptb Ratio | 12.03 | 17.85 | 7.92 | 4.09 | 3.77 | 3.58 | |
| Days Sales Outstanding | 17.15 | 16.59 | 28.28 | 42.97 | 22.86 | 21.72 | |
| Free Cash Flow Yield | (0.0862) | (0.0366) | (0.0978) | (0.13) | 0.065 | 0.0682 | |
| Stock Based Compensation To Revenue | 0.15 | 0.12 | 0.0918 | 0.0797 | 0.0569 | 0.054 | |
| Capex To Depreciation | 0.49 | 0.0939 | 0.25 | 0.18 | 0.0868 | 0.0825 | |
| Pb Ratio | 12.03 | 17.85 | 7.92 | 4.09 | 3.77 | 3.58 | |
| Ev To Sales | 4.94 | 4.7 | 3.38 | 1.4 | 1.0 | 0.95 | |
| Roic | (1.44) | (1.08) | (0.79) | (0.55) | (0.19) | (0.2) | |
| Inventory Turnover | 1.78 | 2.05 | 1.91 | 1.99 | 2.26 | 2.66 | |
| Net Income Per Share | (0.55) | (0.3) | (0.38) | (0.21) | (0.0659) | (0.0691) | |
| Days Of Inventory On Hand | 205.16 | 177.8 | 191.24 | 183.13 | 161.68 | 132.46 | |
| Research And Ddevelopement To Revenue | 0.0955 | 0.063 | 0.0568 | 0.067 | 0.0593 | 0.0598 | |
| Capex To Revenue | 0.0163 | 0.002396 | 0.006064 | 0.004636 | 0.001771 | 0.001682 | |
| Cash Per Share | 0.33 | 0.27 | 0.42 | 0.29 | 0.36 | 0.38 | |
| Pocfratio | (12.03) | (27.65) | (10.4) | (7.76) | 15.07 | 15.82 | |
| Interest Coverage | (36.95) | (279.63) | (492.24) | (6.2K) | (7.1K) | (6.8K) | |
| Capex To Operating Cash Flow | (0.0368) | (0.0134) | (0.0169) | (0.0221) | 0.0208 | 0.0218 | |
| Pfcf Ratio | (11.6) | (27.29) | (10.23) | (7.59) | 15.39 | 16.16 | |
| Income Quality | 0.64 | 0.53 | 0.89 | 0.91 | (1.44) | (1.37) | |
| Roe | (1.54) | (1.13) | (0.81) | (0.5) | (0.17) | (0.18) | |
| Ev To Operating Cash Flow | (11.2) | (26.25) | (9.43) | (6.7) | 11.69 | 12.27 | |
| Pe Ratio | (7.81) | (15.86) | (9.83) | (8.11) | (21.71) | (22.8) | |
| Return On Tangible Assets | (0.81) | (0.5) | (0.45) | (0.27) | (0.0907) | (0.0952) | |
| Ev To Free Cash Flow | (10.8) | (25.9) | (9.28) | (6.56) | 11.94 | 12.53 | |
| Earnings Yield | (0.13) | (0.0631) | (0.1) | (0.12) | (0.0461) | (0.0484) | |
| Intangibles To Total Assets | 0.0326 | 0.0282 | 0.0148 | 0.0124 | 0.009279 | 0.008815 | |
| Net Debt To E B I T D A | 0.57 | 0.81 | 0.92 | 0.95 | 6.18 | 6.48 | |
| Current Ratio | 2.23 | 1.96 | 2.78 | 2.61 | 2.4 | 1.88 | |
| Receivables Turnover | 21.28 | 22.0 | 12.91 | 8.49 | 15.97 | 8.62 | |
| Graham Number | 2.11 | 1.35 | 2.01 | 1.38 | 0.75 | 0.93 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 1.215 | Quarterly Revenue Growth 0.312 | Return On Assets 0.0051 | Return On Equity 0.0482 |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.